The evaluation of the efficacy and safety of oral fingolimod in relapsing remitting multiple sclerosis

Authors
Category Primary study
Registry of TrialsIranian Registry of Clinical Trials
Year 2015
This article has no abstract
Epistemonikos ID: 05a87bc39fd8fcd71af2fdb810c30409be3ded36
First added on: Apr 16, 2025